Recurrent Loss of NFE2L2 Exon 2 Is a Mechanism for Nrf2 Pathway Activation in Human Cancers-Reference-Cited by-同舟云学术

Recurrent Loss of NFE2L2 Exon 2 Is a Mechanism for Nrf2 Pathway Activation in Human Cancers

Published:2016-09 Issue:10 Volume:16 Page:2605-2617
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Goldstein Leonard D.,Lee James,Gnad Florian,Klijn Christiaan,Schaub Annalisa,Reeder Jens,Daemen Anneleen,Bakalarski Corey E.,Holcomb Thomas,Shames David S.,Hartmaier Ryan J.,Chmielecki Juliann,Seshagiri Somasekar,Gentleman Robert,Stokoe David

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference41 articles.

1. Truncated ERG oncoproteins from TMPRSS2-ERG fusions are resistant to SPOP-mediated proteasome degradation;An;Mol. Cell,2015

2. Differential expression analysis for sequence count data;Anders;Genome Biol.,2010

3. Seven in absentia homolog 2 (Siah2) protein is a regulator of NF-E2-related factor 2 (Nrf2);Baba;J. Biol. Chem.,2013

4. Comprehensive genomic characterization of squamous cell lung cancers;Nature,2012

5. Comprehensive molecular profiling of lung adenocarcinoma;Nature,2014

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Growth Inhibitory Effect of Resveratrol and Gallic Acid on Prostate Cancer Cell Lines through the Alteration of Oxidative Stress Balance: The Interplay between Nrf2, HO-1, and BACH1 Genes;Anti-Cancer Agents in Medicinal Chemistry;2024-10

2. A Core NRF2 Gene Set Defined Through Comprehensive Transcriptomic Analysis Predicts Selective Drug Resistance and Poor Multicancer Prognosis;Antioxidants & Redox Signaling;2024-08-08

3. Tamoxifen metabolites treatment promotes ERα+ transition to triple negative phenotype in vitro, effects of LDL in chemoresistance;Bioscience Reports;2024-08

4. Development of Mutated β-catenin Gene Signature to identify CTNNB1 mutations from whole and spatial transcriptomic data in patients with HCC;JHEP Reports;2024-08

5. CRISPR activation screens identify the SWI/SNF ATPases as suppressors of ferroptosis;Cell Reports;2024-06